| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a7b2b857943c7b68a4dea0e8f78d26f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-26 |
| filingDate |
2007-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c984b501602586e08847a85a4a658d3 |
| publicationDate |
2008-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101323610-A |
| titleOfInvention |
Novel preparation of trityl group candesartan cilexetil intermediate |
| abstract |
The invention discloses a novel technology for synthesizing an intermediate of trityl candesartan; the synthesis steps thereof comprise: (1) a preparation method of 2-menthyl formate-6-nitryl-benzoic acid; (2) a preparation method of 2-amido-3-nitryl-methyl benzoate; (3) a preparation method of 2, 3-diaminobenzene menthyl formate; (4) a preparation method of 2-oxethyl-4-menthyl formate-3-H-benzimidazole; and (5) the preparation method of the intermediate of trityl candesartan. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104876877-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102702176-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102712606-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102702176-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103922948-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749195-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109608434-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109195952-A |
| priorityDate |
2007-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |